Neoplasm Recurrence, Local
"Neoplasm Recurrence, Local" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site.
| Descriptor ID |
D009364
|
| MeSH Number(s) |
C04.697.655 C23.550.727.655
|
| Concept/Terms |
Neoplasm Recurrence, Local- Neoplasm Recurrence, Local
- Local Neoplasm Recurrences
- Locoregional Neoplasm Recurrence
- Recurrences, Local Neoplasm
- Neoplasm Recurrences, Local
- Recurrence, Local Neoplasm
- Recurrence, Locoregional Neoplasm
- Local Neoplasm Recurrence
- Neoplasm Recurrence, Locoregional
- Locoregional Neoplasm Recurrences
- Neoplasm Recurrences, Locoregional
- Recurrences, Locoregional Neoplasm
|
Below are MeSH descriptors whose meaning is more general than "Neoplasm Recurrence, Local".
Below are MeSH descriptors whose meaning is more specific than "Neoplasm Recurrence, Local".
This graph shows the total number of publications written about "Neoplasm Recurrence, Local" by people in this website by year, and whether "Neoplasm Recurrence, Local" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 4 | 4 |
| 1996 | 1 | 4 | 5 |
| 1997 | 0 | 6 | 6 |
| 1998 | 1 | 8 | 9 |
| 1999 | 2 | 0 | 2 |
| 2000 | 4 | 7 | 11 |
| 2001 | 1 | 15 | 16 |
| 2002 | 7 | 5 | 12 |
| 2003 | 6 | 8 | 14 |
| 2004 | 7 | 13 | 20 |
| 2005 | 8 | 13 | 21 |
| 2006 | 11 | 15 | 26 |
| 2007 | 14 | 7 | 21 |
| 2008 | 12 | 6 | 18 |
| 2009 | 9 | 14 | 23 |
| 2010 | 19 | 22 | 41 |
| 2011 | 10 | 22 | 32 |
| 2012 | 15 | 5 | 20 |
| 2013 | 23 | 21 | 44 |
| 2014 | 23 | 14 | 37 |
| 2015 | 28 | 20 | 48 |
| 2016 | 23 | 16 | 39 |
| 2017 | 25 | 22 | 47 |
| 2018 | 24 | 26 | 50 |
| 2019 | 22 | 23 | 45 |
| 2020 | 25 | 30 | 55 |
| 2021 | 12 | 42 | 54 |
| 2022 | 7 | 52 | 59 |
| 2023 | 2 | 41 | 43 |
| 2024 | 21 | 23 | 44 |
| 2025 | 24 | 6 | 30 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neoplasm Recurrence, Local" by people in Profiles.
-
Carbonic Anhydrase Inhibition Sensitizes Group 3 Medulloblastoma to Radiotherapy. Cancer Res. 2025 Oct 01; 85(19):3737-3751.
-
Feasibility of Atezolizumab in Combination With Chemotherapy for Children With Relapsed or Refractory Solid Tumors. Pediatr Blood Cancer. 2025 Dec; 72(12):e32046.
-
A Phase I, Open-Label, Dose Escalation Study of Enoblituzumab in Children and Young Adults with B7-H3-Expressing Relapsed or Refractory Solid Tumors. Cancer Res Commun. 2025 Sep 01; 5(9):1574-1583.
-
ACR Neck Imaging Reporting and Data System for MRI Version 2025. J Am Coll Radiol. 2025 Nov; 22(11):1325-1336.
-
Impact of NOTCH1 expression in primary breast adenoid cystic carcinoma. J Clin Pathol. 2025 Jul 18; 78(8):548-553.
-
Molecular and clinical determinants of response to checkpoint inhibitor immunotherapy in glioblastoma. J Neurooncol. 2025 Oct; 175(1):453-461.
-
Relapse patterns among children and adolescents with Kaposi sarcoma in Malawi. Pediatr Hematol Oncol. 2025 Aug; 42(5):276-286.
-
Radiographic and visual response to the type II RAF inhibitor tovorafenib in children with relapsed/refractory optic pathway glioma in the FIREFLY-1 trial. Neuro Oncol. 2025 Jun 21; 27(5):1341-1355.
-
Late Recurrence of Spindle Cell Sarcoma in Association with TPM3::NTRK1 Fusion. Int J Surg Pathol. 2025 Dec; 33(8):1709-1712.
-
Long-Term (=5-Year) Remission and Survival After Treatment With Ciltacabtagene Autoleucel in CARTITUDE-1 Patients With Relapsed/Refractory Multiple Myeloma. J Clin Oncol. 2025 Sep; 43(25):2766-2771.